We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+12.59%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$18.9B
AUM Growth
+$3.55B
(+23%)
Cap. Flow
+$2.11B
Cap. Flow
% of AUM
11.15%
Top 10 Holdings %
Top 10 Hldgs %
14.56%
Holding
1,090
New
199
Increased
468
Reduced
192
Closed
179
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$216M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$129M |
| 3 |
Brown & Brown
BRO
|
+$121M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$116M |
| 5 |
AKRO
Akero Therapeutics
AKRO
|
+$90.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$144M |
| 2 |
MetLife
MET
|
+$97.2M |
| 3 |
Travelers Companies
TRV
|
+$91.9M |
| 4 |
Electronic Arts
EA
|
+$91.9M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.08% |
| 2 | Technology | 23.91% |
| 3 | Financials | 10.59% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Industrials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Hewlett Packard
HPE
$66.5B
| $18.8M | 0.1% |
+920,501
| New | +$15.4M |
|
302
Morgan Stanley
MS
$332B
| $18.8M | 0.1% |
133,620
+29,079
| +28% | +$3.57M |
|
303
Vita Coco
COCO
$3.67B
| $18.8M | 0.1% |
+520,065
| New | +$17.4M |
|
304
Universal Health Services
UHS
$10.2B
| $18.6M | 0.1% |
102,821
+97,861
| +1,973% | +$17.7M |
|
305
Mueller Water Products
MWA
$4.04B
| $18.6M | 0.1% |
+774,613
| New | +$19.2M |
|
306
Mettler-Toledo International
MTD
$29B
| $18.6M | 0.1% |
15,820
+356
| +2% | +$398K |
|
307
The Mosaic Company
MOS
$6.93B
| $18.6M | 0.1% |
509,398
+482,562
| +1,798% | +$15.5M |
|
308
Becton Dickinson
BDX
$46.9B
| $18.4M | 0.1% |
106,578
-109,158
| -51% | -$20M |
|
309
Acadia Pharmaceuticals
ACAD
$4.39B
| $18.1M | 0.1% |
837,199
+541,989
| +184% | +$10.1M |
|
|
RNAM
310
DELISTED
Avidity Biosciences
RNAM
| $18M | 0.1% |
635,094
-230,831
| -27% | -$6.88M |
|
311
S&P Global
SPGI
$123B
| $17.9M | 0.09% |
33,954
+7,340
| +28% | +$3.66M |
|
312
Adient
ADNT
$1.65B
| $17.9M | 0.09% |
+917,732
| New | +$13.6M |
|
313
Syndax Pharmaceuticals
SNDX
$1.7B
| $17.7M | 0.09% |
1,892,751
+948
| +0.1% | +$10.4K |
|
314
JFrog
FROG
$9.98B
| $17.4M | 0.09% |
+396,965
| New | +$15.1M |
|
315
Autoliv
ALV
$9.07B
| $17.3M | 0.09% |
+154,723
| New | +$15.1M |
|
316
Citigroup
C
$224B
| $17.2M | 0.09% |
202,031
+43,444
| +27% | +$3.14M |
|
317
AXIS Capital
AXS
$7.72B
| $17M | 0.09% |
163,474
-206,580
| -56% | -$20.6M |
|
|
SCHW
318
Charles Schwab
SCHW
$184B
| $16.9M | 0.09% |
184,748
+40,776
| +28% | +$3.41M |
|
319
Atmus Filtration Technologies
ATMU
$4.4B
| $16.7M | 0.09% |
458,242
+300,875
| +191% | +$10.7M |
|
320
Globe Life
GL
$14.3B
| $16.6M | 0.09% |
133,716
-28,152
| -17% | -$3.42M |
|
321
Dana Inc
DAN
$2.97B
| $16.6M | 0.09% |
967,424
+535,783
| +124% | +$8M |
|
322
Starbucks
SBUX
$118B
| $16.6M | 0.09% |
181,021
-180,052
| -50% | -$15.6M |
|
323
Blackrock
BLK
$175B
| $16.5M | 0.09% |
15,753
+3,453
| +28% | +$3.27M |
|
324
Meritage Homes
MTH
$4.71B
| $16.4M | 0.09% |
245,171
+42,148
| +21% | +$2.79M |
|
325
Camden Property Trust
CPT
$11B
| $16.4M | 0.09% |
145,234
-229,898
| -61% | -$26.5M |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q2 2025 Portfolio in Review
As of Q2 2025, Woodline Partners held 1,090 positions worth $18.9B, up 23% from $15.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Woodline Partners deployed $2.11B of net new capital in Q2 2025, opening 199 new positions and adding to 468 existing holdings. Its largest new stake was Brown & Brown: 1,079,076 shares worth $120M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was SpringWorks Therapeutics, an estimated $76M trimmed.
- Woodline Partners's largest Q2 2025 buy was Brown & Brown: 1,079,076 shares worth $120M.
- Woodline Partners added most to Microsoft in Q2 2025, an estimated $216M increase.
- Woodline Partners's biggest Q2 2025 reduction was SpringWorks Therapeutics, cutting an estimated $76M.
- Woodline Partners fully exited Lam Research in Q2 2025, selling an estimated $144M.
- Woodline Partners's ten largest holdings make up 15% of its $18.9B portfolio in Q2 2025.
- Woodline Partners opened 199 new positions and closed 179 in Q2 2025.
- Woodline Partners's portfolio value rose 23% quarter-over-quarter to $18.9B.
Based on Woodline Partners's 13F filing for Q2 2025, filed 14 Aug 2025.